A UNIQUE STABILISED INJECTABLE HYALURONIC ACID FOR TREATING SKIN LAXITY
Stabilsed hybrid cooperative complexes is the first and only product developed with Nahyco®.
A unique and innovative thermal production process patented by IBSA.
PROFHILO® is based on stabilsed hybrid cooperative complex, and it is the pioneer of BIOREMODELLING. It is the first product developed with NAHYCO® technology, a unique and innovative thermal production process, 100% free of chemical stabilising agents, patented by IBSA.
PROFHILO® is indicated for TISSUE REMODELING AND IMPROVEMENT IN SKIN LAXITY of face, neck, and décolletage. PROFHILO® promotes the restoration of firmness, tone and elasticity of tissues in an authentic way, leading to a DYNAMIC MULTILEVEL REMODELLING of the extracellular matrix in terms of elasticity and support, as well as maintaining and promoting the normal vitality of Fibroblasts, Keratinocytes and Adipocytes.
Unique characteristics of the product are: natural HA with a duration comparable to a low cross-linked gel, high HA concentration (64mg/2ml), high manageability, extensive spreadability, low viscosity, no BDDE or other chemical agents, and low inflammatory response.
Profhilo® is not a dermal filler or biorevitaliser - Profhilo® has opened up a new injectable category - bioremodeling.
Thermal cross-linking changes the character and behavior of the HA resulting in the formation of co-operative hybrid complexes which modulate the tissues. This is also the explanation for the different biological behavior with respect to H-HA and L-HA alone. One of the main advantages is longevity. Hybrid cooperative complexes have proven to be very stable with natural hyaluronidase (BTH) digestion when compared to H-HA, widely used in biorevitalisation products, or L-HA alone resulting in the long-lasting release and the dual action of the two HA components. This dual action is ideal for remodeling skin laxity.
To maximise the diffusion in the malar andf sub-malar areas: